True resistant hypertension is relatively frequent, yet effective treatment is often difficult to identify. In a new study, de Souza and colleagues demonstrate the potent blood pressure lowering effect of low-dose spironolactone in patients with evident resistant hypertension. This finding should have broad clinical implications in the effective management of a notoriously challenging condition.